Drug-Eluting Stents Market Set to Surge to $8,777 Million by 2027 at a 8.7% CAGR

The global drug-eluting stents market has experienced significant growth in recent years, driven by advancements in medical technology and an increasing prevalence of cardiovascular diseases. In 2019, the drug-eluting stents market was valued at $6,382 million and is projected to reach $8,777 million by 2027, registering a CAGR of 8.7% from 2020 to 2027.

Read More: https://www.alliedmarketresearch.com/drug-eluting-stents-market-A10604

Drug-Eluting Stents Market Growth Factors

Several factors contribute to the growth of the drug-eluting stents market:

- Rising Prevalence of Cardiovascular Diseases: Sedentary lifestyles, unhealthy eating habits, and lack of exercise have led to an increase in conditions like atherosclerosis, necessitating the use of drug-eluting stents.

- Technological Advancements: Innovations in stent design, such as the development of biodegradable polymers and polymer-free coatings, enhance patient outcomes by reducing complications like in-stent restenosis.

- Aging Population: The global increase in the elderly population, who are more susceptible to cardiovascular ailments, drives the demand for effective treatments like drug-eluting stents.

- Minimally Invasive Procedures: The preference for minimally invasive interventions has boosted the adoption of drug-eluting stents, as they offer quicker recovery times and reduced hospital stays compared to traditional surgical methods.

Get Sample PDF Copy Here: https://www.alliedmarketresearch.com/request-sample/A10604

Drug-Eluting Stents Market Segmentation

The drug-eluting stents market is segmented based on coating type, application, end user, and region.

1. By Coating Type:
- Polymer-Based Coating: This segment is further divided into biodegradable and non-biodegradable coatings.
- Polymer-Free Coating: Subcategories include microporous surface, microstructured surface, slotted tubular surface, and nanoporous surface.

2. By Application:
- Coronary Artery Disease (CAD): A significant portion of the market is dedicated to the treatment of CAD, given its high prevalence globally.
- Peripheral Artery Disease (PAD): This segment addresses the use of drug-eluting stents in peripheral arteries.

3. By End User:
- Hospitals: Primary centers for stent implantation procedures.
- Ambulatory Surgical Centers: These centers are increasingly adopting stent procedures due to their cost-effectiveness and efficiency.
- Others: Includes specialized clinics and research institutes.

4. By Region:
- North America: Holds a significant share due to advanced healthcare infrastructure and high adoption rates of new technologies.
- Europe: Demonstrates substantial market presence with a focus on innovative medical solutions.
- Asia-Pacific: Expected to exhibit the highest CAGR of 10.0% during 2020-2027, driven by a growing geriatric population and increasing healthcare investments.
- LAMEA (Latin America, Middle East, and Africa): Emerging markets with potential growth opportunities due to improving healthcare access.

Key Players in the Drug-Eluting Stents Market

The drug-eluting stents market features several prominent companies dedicated to advancing cardiovascular care:

- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic Plc.
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Terumo Corporation
- MicroPort Scientific Corporation
- Biosensors International Group
- Elixir Medical Corporation
- Cook Medical

These companies are at the forefront of research and development, striving to introduce innovative products that improve patient outcomes and address the evolving needs of the healthcare industry.

The drug-eluting stents market is poised for substantial growth, driven by technological innovations, an increasing burden of cardiovascular diseases, and a global shift towards minimally invasive medical procedures. As key players continue to invest in research and development, the market is expected to offer advanced solutions that enhance patient care and address the challenges associated with cardiovascular interventions.

Procure Complete Report Here: https://www.alliedmarketresearch.com/checkout-final/1bd74673c6728cec7ba17287107e8407?utm_source=Nilesh.Musale

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.